Yeast in the Gut: From commensals to infectious agents;Übersichtsarbeit: Pilze im Darm - Von kommensalen untermietern zu infektions - erregern

Deutsches Arzteblatt

Volumn 106, Issue 51-52, 2009, Pages 837-842

  Schulze, Jürgen ^a   Sonnenborn, Ulrich ^a  

^a NONE

Author keywords

Candidiasis; Gastrointestinal mycosis; Pathogenesis; Treatment; Yeast infection

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NATAMYCIN; NYSTATIN; POSACONAZOLE; PROBIOTIC AGENT; VIRULENCE FACTOR; VORICONAZOLE;

CANDIDA; COMMENSAL; GENE EXPRESSION; HEALTH HAZARD; HOST RESISTANCE; INFECTION; INVASIVE CANDIDIASIS; MEDLINE; MUCOCUTANEOUS CANDIDIASIS; REVIEW; YEAST; CANDIDIASIS; ENTEROCOLITIS; HUMAN; INCIDENCE; INTESTINE; MICROBIOLOGY; RISK ASSESSMENT; RISK FACTOR;

CANDIDA; CANDIDIASIS; ENTEROCOLITIS; HUMANS; INCIDENCE; INTESTINES; RISK ASSESSMENT; RISK FACTORS;

EID: 77949396850     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0837     Document Type: Review

References (24)

1. Kommission ̈Methoden und Qualitätssicherung in der Umweltmedizin": Pathogenetische Bedeutung der intestinalen Candidabesiedelung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2004; 47: 587-600.
2. Schulze J, Sonnenborn U, Ölschläger T, Kruis W: Probiotika. Mikroökologie, Mikrobiologie, Qualität, Sicherheit und gesundheitliche Effekte. Stuttgart: Hippokrates 2008; 4-16.
3. Bernhardt H, Knoke M: Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 1997; 32 (Suppl 222): 102-6.
4. Hube B: From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 2004; 7: 336-41.
5. Netea MG, Brown GD, Kullberg BJ, Gow NAR: An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Immunol 2008; 6: 67-78.
6. Raska M, Belakova J, Krupka M, Weigl E: Candidiasis - Do we need to fight or to tolerate the Candida fungus? Folia Microbiol 2007; 52: 297-312.
7. Mathews HL, Witek-Janusek L: Host defense against oral, esophageal, and gastrointestinal candidiasis. In: Calderone RA (ed.): Candida and candidiasis. Washington: ASM Press 2002; 179-92.
8. Biswas S, Van Dijck P, Datta A: Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 2007; 71: 348-76.
9. Piispanen AE, Hogan DA: PEPped up: induction of Candida albicans virulence by bacterial cell wall fragments. Cell Host Microbe 2008; 4: 1-2.
10. Thewes S, Kretschmar M, Park H, Schaller M, Filler SG, Hube B: In vivo and ex vivo comparative transcriptional profiling of invasive and noninvasive Candida albicans isolates identifies genes associated with tissue invasion. Mol Microbiol 2007; 63: 1606-28.
11. Morschhäuser J, Köhler G, Ziebuhr W, Blum-Oehler G, Dobrindt U, Hacker J: Evolution of microbial pathogens. Phil Trans R Soc Lond 2000; 355: 695-704.
12. Calderone RA, Fonzi WA: Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327-35.
13. Douglas LJ: Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-6.
14. Soll DR: Phenotypic switching. In: Calderone RA (ed.): Candida and Candidiasis. Washington: ASM Press 2002; 123-42.
15. Bastidas RJ, Heitman J: Trimorphic stepping stones pave the way to fungal virulence. PNAS 2009; 106: 351-2.
16. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN , Huffnagle GB: Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 2005; 73: 30-8. 17. Xu XL, Lee RTH, Fang HM, Wang YM, Li R, Zou H, et al.: Bacterial pepti-doglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase cyr1p. Cell Host Microbe 2008; 4: 28-39.
17. Polakova S, Blume C, Zarate JA, Mentel M, Jorck-Ramberg D, Stenderup J, et al.: Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. PNAS 2009; 106: 2688-93.
18. Morita E, Hide M, Yoneya Y, Kannbe M, Tanaka A, Yamamoto S: An assessment of the role of Candida albicans antigen in atopic dermatitis. J Dermatol 1999; 26: 282-7.
19. Pappas PG, Rex JH, Sobel JD, et al.: Guidelines for treatment of Candidiasis. CID 2004; 38: 161-89.
20. Reinel D, Plettenberg A, Seebacher C, et al.: Orale Candidose. Leitlinie der Deutschen Dermatologischen Gesellschaft und der Deutschsprachigen Mykologischen Gesellschaft. JDDG 2008; 7: 593-7.
21. Cruciani M, de Lalla F, Mengoli C: Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intens Med Care 2005; 31: 1479-87.
22. Zwolinska-Wcislo M, Brozozowski T, Mach T, et al.: Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006; 57 (Suppl 9): 35-49.
23. Manzoni P, Mostert M, Leonessa ML, et al.: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric coloniza - tion by Candida species in preterm neonates: A randomized study. Clin Infect Dis 2006; 42: 1735-42.
24. Hatakka K, Ahola AJ, Yli-Knuuttila, et al.: Probiotics reduce the pre-valence of oral Candida in the elderly - a randomized controlled trial. J Dent Res 2007; 86: 125-30.